Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable mRNA binding activity. Acts upstream of or within negative regulation of mRNA splicing, via spliceosome. Predicted to be active in nucleus. Is expressed in several structures, including central nervous system; genitourinary system; liver; sensory organ; and thymus primordium. Orthologous to human PTBP3 (polypyrimidine tract binding protein 3).